banner
Topoisomerase inhibitor, Zoliflodacin, Purity ≥98%
Inquiry

Cat. No.: X24-08-YM072

Topoisomerase inhibitor, Zoliflodacin, Purity ≥98%

Synonym: 1620458-09-4; ETX0914; ETX-0914; ETX 0914; AZD0914; AZD 0914; AZD-0914; (4'R,6'S,7'S)-17'-Fluoro-4',6'-dimethyl-13'-[(4S)-4-methyl-2-oxo-1,3-oxazolidin-3-yl]spiro[1,3-diazinane-5,8'-5,15-dioxa-2,14-diazatetracyclo[8.7.0.02,7.012,16]heptadeca-1(17),10,12(16),13-tetraene]-2,4,6-trione

  • CAS Number: 1620458-09-4
  • Compound CID: 76685216
img
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Zoliflodacin is an effective DNA damage inhibitor, that has the ability to prevent the pathway of DNA damage by inhibiting topoisomerase.
Molecular Weight
487.44
Molecular Formula
C22H22FN5O7
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Applications
Zoliflodacin is a DNA damage inhibitor that plays a key role in inhibiting bacterial DNA gyrase and topoisomerase IV, crucial enzymes for bacterial DNA replication and repair.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0